CATHY KLEMA

Insider Reports History

Signature
/s/ Marion Odence-Ford, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CATHY KLEMA:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OptimizeRx Corp Director Common Stock 21.6K $238K $11.01 11 Jun 2025 Direct
OptimizeRx Corp Director Restricted Stock Units 0 $0 $10.70 02 Feb 2025 Direct

Insider Reports Filed by CATHY KLEMA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OPRX OptimizeRx Corp 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:36
OPRX OptimizeRx Corp 02 Feb 2025 2 $0 4 Director 04 Feb 2025, 18:50
OPRX OptimizeRx Corp 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 17:47
OPRX OptimizeRx Corp 02 Feb 2024 1 $0 4 Director 06 Feb 2024, 19:53
OPRX OptimizeRx Corp 24 Jan 2024 0 $0 3 Director 02 Feb 2024, 17:04